622 related articles for article (PubMed ID: 23835194)
1. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
3. WNT signaling pathway and stem cell signaling network.
Katoh M; Katoh M
Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
[TBL] [Abstract][Full Text] [Related]
4. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling.
Miao CG; Yang YY; He X; Li XF; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Cell Signal; 2013 Oct; 25(10):2069-78. PubMed ID: 23602936
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling in adult intestinal stem cells and cancer.
Krausova M; Korinek V
Cell Signal; 2014 Mar; 26(3):570-9. PubMed ID: 24308963
[TBL] [Abstract][Full Text] [Related]
7. Wnt/Frizzled signaling in hepatocellular carcinoma.
Lee HC; Kim M; Wands JR
Front Biosci; 2006 May; 11():1901-15. PubMed ID: 16368566
[TBL] [Abstract][Full Text] [Related]
8. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH
Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129
[TBL] [Abstract][Full Text] [Related]
9. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells.
Etheridge SL; Spencer GJ; Heath DJ; Genever PG
Stem Cells; 2004; 22(5):849-60. PubMed ID: 15342948
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
13. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
14. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
Xu MX; Zhao L; Deng C; Yang L; Wang Y; Guo T; Li L; Lin J; Zhang L
Int J Oncol; 2013 Dec; 43(6):1951-9. PubMed ID: 24064724
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.
Jung KH; Kim JK; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Park WS; Lee JY; Nam SW
J Cell Biochem; 2010 Jun; 110(3):687-96. PubMed ID: 20512928
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling in liver cancer.
Takigawa Y; Brown AM
Curr Drug Targets; 2008 Nov; 9(11):1013-24. PubMed ID: 18991612
[TBL] [Abstract][Full Text] [Related]
18. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
19. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
20. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
